PROTAC Virus, a Novel Vaccine Strategy
Si et al. propose an innovative vaccine strategy that utilizes PROTAC technology to create artificially attenuated influenza strains, a strategy that promises to overcome the limitations of traditional vaccine preparation methods. By linking the proteasome-targeting domain (PTD) to a specific protein of the influenza virus, and using the host cell’s ubiquitin-proteasome system, they successfully degraded […]